Results
|
|
6181.
|
|
|
|
6182.
|
|
|
|
6183.
|
|
|
|
6184.
|
Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients. [electronic resource] by
- Banys-Paluchowski, Malgorzata
- Witzel, Isabell
- Riethdorf, Sabine
- Rack, Brigitte
- Janni, Wolfgang
- Fasching, Peter Andreas
- Solomayer, Erich-Franz
- Aktas, Bahriye
- Kasimir-Bauer, Sabine
- Pantel, Klaus
- Fehm, Tanja
- Müller, Volkmar
Producer: 20170821
In:
Anticancer research vol. 37
Availability: No items available.
|
|
|
6185.
|
|
|
|
6186.
|
|
|
|
6187.
|
Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. [electronic resource] by
- Cohn, David E
- Sill, Michael W
- Walker, Joan L
- O'Malley, David
- Nagel, Christa I
- Rutledge, Teresa L
- Bradley, William
- Richardson, Debra L
- Moxley, Katherine M
- Aghajanian, Carol
Producer: 20170919
In:
Gynecologic oncology vol. 146
Availability: No items available.
|
|
|
6188.
|
CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation. [electronic resource] by
- Dall'Acqua, Alessandra
- Sonego, Maura
- Pellizzari, Ilenia
- Pellarin, Ilenia
- Canzonieri, Vincenzo
- D'Andrea, Sara
- Benevol, Sara
- Sorio, Roberto
- Giorda, Giorgio
- Califano, Daniela
- Bagnoli, Marina
- Militello, Loredana
- Mezzanzanica, Delia
- Chiappetta, Gennaro
- Armenia, Joshua
- Belletti, Barbara
- Schiappacassi, Monica
- Baldassarre, Gustavo
Producer: 20180524
In:
EMBO molecular medicine vol. 9
Availability: No items available.
|
|
|
6189.
|
|
|
|
6190.
|
Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma. [electronic resource] by
- Han, Hee Dong
- Cho, Young-Jae
- Cho, Sung Keun
- Byeon, Yeongseon
- Jeon, Hat Nim
- Kim, Hye-Sun
- Kim, Byoung-Gie
- Bae, Duk-Soo
- Lopez-Berestein, Gabriel
- Sood, Anil K
- Shin, Byung Cheol
- Park, Yeong-Min
- Lee, Jeong-Won
Producer: 20170615
In:
Molecular cancer therapeutics vol. 15
Availability: No items available.
|
|
|
6191.
|
Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study. [electronic resource] by
- Olawaiye, Alexander B
- Java, James J
- Krivak, Thomas C
- Friedlander, Michael
- Mutch, David G
- Glaser, Gretchen
- Geller, Melissa
- O'Malley, David M
- Wenham, Robert M
- Lee, Roger B
- Bodurka, Diane C
- Herzog, Thomas J
- Bookman, Michael A
Producer: 20181109
In:
Gynecologic oncology vol. 151
Availability: No items available.
|
|
|
6192.
|
|
|
|
6193.
|
|
|
|
6194.
|
|
|
|
6195.
|
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study. [electronic resource] by
- Behbakht, Kian
- Sill, Michael W
- Darcy, Kathleen M
- Rubin, Stephen C
- Mannel, Robert S
- Waggoner, Steven
- Schilder, Russell J
- Cai, Kathy Q
- Godwin, Andrew K
- Alpaugh, R Katherine
Producer: 20111108
In:
Gynecologic oncology vol. 123
Availability: No items available.
|
|
|
6196.
|
|
|
|
6197.
|
A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer. [electronic resource] by
- Chianese-Bullock, Kimberly A
- Irvin, William P
- Petroni, Gina R
- Murphy, Cheryl
- Smolkin, Mark
- Olson, Walter C
- Coleman, Elizabeth
- Boerner, Scott A
- Nail, Carmel J
- Neese, Patrice Y
- Yuan, Arlene
- Hogan, Kevin T
- Slingluff, Craig L
Producer: 20080904
In:
Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 31
Availability: No items available.
|
|
|
6198.
|
|
|
|
6199.
|
|
|
|
6200.
|
|